Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stocks slumped on Tuesday. Pessimism continues to permeate Wall Street as global events reinforce a hawkish stance on rates. Japan recently adjusted the cap on its 10-year government bond yield, which weighed on investors as central banks around the world continue their aggressive monetary policy. With this consistent negative sentiment in the markets, it's crucial to make sure your money is protected heading into the new year. Our Head Fundamental Tactician Karim Rahemtulla is showing traders a unique investment opportunity outside of traditional markets. It's only $3, and there's a good reason you'll want to get in before January 6, 2023. Click here to discover this $3 alternative strategy. Here's a look at the top-moving stocks this morning. IceCure Medical (Nasdaq: ICCM) IceCure Medical is up $178.66% premarket as the Israel-based medical device maker announced successful studies pertaining to its kidney tumor treatment at a Urological Association conference in Israel. The stock was up as much as 1,000% before pulling back. Its device is called Prosense, a minimally invasive medical device that seeks to destroy tumors by freezing them in a process called cryoblation. Medical devices can be truly innovative when they live up to the hype. They could also lead to big gains in the stock market. Right now our friend Alexander Green wants traders to know about another medical device company. It's currently trading for under $3 and Green says 'it's the most incredible investment opportunity I've seen in 37 years.' Click here to unlock this cheap medical stock. Lucid Group, Inc. (Nasdaq: LCID) Lucid Group is up 5.12% premarket after the company raised more than $1.5 billion. The EV company sold more than 56.2 million shares of its common stock for gross proceeds of approximately $600 million. Lucid expects that the additional capital raised will further strengthen ts balance sheet and liquidity position. |
No comments:
Post a Comment